Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Bio-Techne from $85.00 to $82.00 and set a "buy" rating for the company in a research report on Thursday. Read this story
Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Bio-Techne from $85.00 to $82.00 and set a "buy" rating for the company in a research report on Thursday. Read this story
More from MarketBeat | Bio-Techne instant alerts NASDAQ:TECH lower price target Stock market Nasdaq Deutsche Bank AG